South Korea’s exports jumped 20.2 percent last month from a year earlier expanding at the fastest clip in five years on rising oil prices and recovering world trade, government data showed Wednesday. Outbound shipments came to $43.2 billion in February, up from $35.9 billion tallied a year earlier, according to the Ministry of Trade, Industry
The post Korea's exports rise 20.2% in Feb. appeared first on Made in Korea Products Blog by Best Made in Korea.
Read More
South Korea’s Celltrion announced Wednesday that the European Medicines Agency has granted sales approval to Truxima, its biosimilar drug referencing Roche’s blockbuster lymphatic cancer drug Rituxan. Truxima is the first ever Rituxan (rituximab) biosimilar to be approved by the European drug regulator, as well as the first ever Europe-approved biosimilar monoclonal antibody used to target
The post Celltrion’s Rituxan biosimilar wins European approval appeared first on Read More
